On 25 and 26 October, CSL Vifor, a EKPF sponsor, held its internal leadership meeting at its headquarters in Switzerland. Among the topics discussed with its employees was the relationship with a key stakeholder group for this company, namely people with chronic kidney disease. Our president Daniel Gallego represented them. This confirms the growing interest of the pharmaceutical industry in knowing first-hand the perspective of the recipients of their treatments, allowing organisations such as ours to inform their workers of the real needs of our associates. In this way, we promote the needs of people with kidney diseases so that research and production of treatments tailored to the real needs of the people we serve can be carried out.
